Learn about treatment results with TABRECTA
For US residents only.
TABRECTA® (capmatinib) tablets
What is TABRECTA? (ta brek’ tah)
TABRECTA is used to treat adults with NSCLC that:
has spread to other parts of the body or cannot be removed by surgery (metastatic), and
whose tumors have an abnormality in their mesenchymal-epithelial transition (MET) gene
It is not known if TABRECTA is safe and effective in children.
How does TABRECTA work?
TABRECTA works by blocking the activity of proteins made by MET exon 14 skipping that can cause your cancer to grow
TABRECTA affects both cancer cells and healthy cells
Although TABRECTA has been studied in people with NSCLC, how TABRECTA works has been demonstrated only in laboratory studies